Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Works of Bryan A. Faller being referenced
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A
2022 Standout
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bryan A. Faller | 307 | 167 | 189 | 32 | 496 | |
| Riccardo Ricotta | 299 | 189 | 161 | 36 | 498 | |
| Nathalie Letarte | 213 | 136 | 131 | 24 | 456 | |
| Ken Saijo | 224 | 128 | 198 | 46 | 504 | |
| Fernanda I. Arnaldez | 189 | 105 | 201 | 20 | 490 | |
| Pranshu Bansal | 290 | 220 | 118 | 21 | 508 | |
| Olsi Gjyshi | 156 | 142 | 191 | 23 | 519 | |
| Elsa Curtit | 207 | 101 | 74 | 45 | 423 | |
| Manali Rupji | 159 | 102 | 178 | 44 | 453 | |
| Daniele Pozzessere | 226 | 170 | 111 | 24 | 416 | |
| Constanta Timcheva | 372 | 89 | 125 | 23 | 457 |
All Works
Login with ORCID to disown or claim papers
Loading papers...